{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:07:37Z","timestamp":1791378457933,"version":"4.3.2"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004385","name":"Ghent University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011676","name":"Elekta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011010","name":"European SocieTy for Radiotherapy and Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.radonc.2025.111167","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:22:30Z","timestamp":1759591350000},"page":"111167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Building an appraisal framework for radiotherapy innovations in a value-based context: The ESTRO-Value-based radiation oncology categorisation system"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6414-0422","authenticated-orcid":false,"given":"M.","family":"Vandemaele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7330-6308","authenticated-orcid":false,"given":"J.M.","family":"Borr\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6510-1633","authenticated-orcid":false,"given":"M.","family":"Leech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9157-3730","authenticated-orcid":false,"given":"Y.","family":"Lievens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111167_b0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2015.04.018","article-title":"The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis","volume":"116","author":"Borr\u00e0s","year":"2015","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.radonc.2025.111167_b0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.radonc.2016.02.016","article-title":"How many new cancer patients in Europe will require radiotherapy by 2025?","volume":"119","author":"Borras","year":"2016","journal-title":"An ESTRO-HERO analysis Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111167_b0015","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"Atun","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111167_b0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.radonc.2017.10.027","article-title":"Global impact of radiotherapy in oncology: Saving one million lives by 2035","volume":"125","author":"Lievens","year":"2017","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.radonc.2025.111167_b0025","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3109\/0284186X.2015.1066932","article-title":"Cost calculation: a necessary step towards widespread adoption of advanced radiotherapy technology","volume":"54","author":"Lievens","year":"2015","journal-title":"Acta oncologica (Stockholm, Sweden)"},{"key":"10.1016\/j.radonc.2025.111167_b0030","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1016\/S1470-2045(18)30917-3","article-title":"Towards an evidence-informed value scale for surgical and radiation oncology: a multi-stakeholder perspective","volume":"20","author":"Lievens","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111167_b0035","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ijrobp.2018.03.009","article-title":"Radiation Therapy Research: a Global Analysis 2001-2015","volume":"101","author":"Aggarwal","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111167_b0040","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv305","article-title":"Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription","volume":"108","author":"Zindler","year":"2016","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"10.1016\/j.radonc.2025.111167_b0045","series-title":"Basic Clinical Radiobiology","author":"Joiner","year":"2009"},{"key":"10.1016\/j.radonc.2025.111167_b0050","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/annonc\/mdv249","article-title":"A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)","volume":"26","author":"Cherny","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2025.111167_b0055","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"key":"10.1016\/j.radonc.2025.111167_b0060","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1200\/JCO.2015.61.6706","article-title":"American Society of Clinical Oncology Statement: a Conceptual Framework to Assess the Value of Cancer Treatment Options","volume":"33","author":"Schnipper","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111167_b0065","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2021.08.002","article-title":"Innovation, value and reimbursement in radiation and complex surgical oncology: Time to rethink","volume":"169","author":"Borras","year":"2022","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.radonc.2025.111167_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110105","article-title":"A taskforce for national improvement of innovation implementation in radiotherapy","volume":"192","author":"Jacobs","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111167_b0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fonc.2017.00059","article-title":"R-IDEAL: a Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology","volume":"7","author":"Verkooijen","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.111167_b0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radonc.2021.05.007","article-title":"Value-based radiotherapy: a new chapter of the ESTRO-HERO project","volume":"160","author":"Lievens","year":"2021","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.radonc.2025.111167_b0085","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(22)00540-X","article-title":"European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission","volume":"24","author":"Lawler","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111167_b0090","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1080\/0284186X.2017.1348622","article-title":"Access to innovative radiotherapy: how to make it happen from an economic perspective?","volume":"56","author":"Lievens","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.111167_b0095","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.radonc.2016.12.002","article-title":"Cost evaluations of radiotherapy: what do we know?","volume":"121","author":"Defourny","year":"2016","journal-title":"An ESTRO-HERO analysis Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111167_b0100","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp1011024","article-title":"What is Value in Health Care?","volume":"363","author":"Porter","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2025.111167_b0105","series-title":"Boersma LJ","first-page":"94","author":"Swart","year":"2021"},{"key":"10.1016\/j.radonc.2025.111167_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109602","article-title":"A systematic literature review of definitions and classification systems for radiotherapy innovation: a first step towards building a value-based assessment tool for radiation oncology","volume":"183","author":"Vandemaele","year":"2023","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.radonc.2025.111167_b0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/160940690900800406","article-title":"Building a Conceptual Framework: philosophy, Definitions, and Procedure","volume":"8","author":"Jabareen","year":"2009","journal-title":"Int J Qual Methods"},{"key":"10.1016\/j.radonc.2025.111167_b9000","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111165","article-title":"Outcomes and level of evidence in radiation therapy research and different categories of radiotherapy innovations: an ESTRO-VBRO bibliometrics analysis of the literature","author":"Vandemaele","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111167_b0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semradonc.2011.09.008","article-title":"A clinical approach to technology assessment: how do we and how should we choose the right treatment?","volume":"22","author":"Zietman","year":"2012","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111167_b0125","article-title":"How to measure innovation in radiotherapy: an application of the Delphi method","volume":"4","author":"Jacobs","year":"2015","journal-title":"J Hosp Adm"},{"key":"10.1016\/j.radonc.2025.111167_b0130","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/S1470-2045(11)70379-5","article-title":"Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?","volume":"13","author":"van Loon","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111167_b0135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clon.2016.11.011","article-title":"Analysis of Global Radiotherapy needs and costs by Geographic Region and Income Level","volume":"29","author":"Zubizarreta","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025051710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025051710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:15:26Z","timestamp":1780546526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025051710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"alternative-id":["S0167814025051710"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111167","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Building an appraisal framework for radiotherapy innovations in a value-based context: The ESTRO-Value-based radiation oncology categorisation system","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111167"}}